Patents by Inventor John Montague

John Montague has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and systems for automatically generating software applications
    Publication number: 20020092004
    Abstract: The present invention provides systems and methods to build multi-tiered software applications with a high level of quality and complexity. One specific embodiment of the system includes a design application that guides a designer through a system design process, a generator application that generates and customizes a software solution tailored to the system design and an installation application that modularizes and automates the installation and configuration of the generated software solution.
    Type: Application
    Filed: July 26, 2001
    Publication date: July 11, 2002
    Inventors: John Michael Lee, John Montague Howard
  • Tricyclic nitrogen heterocycles as PDE IV inhibitors
    Patent number: 6417190
    Abstract: The invention relates to the use of tricyclic nitrogen heterocycles of general formula I as pharmaceutical compositions with an inhibitory effect on PDE IV, wherein the groups R1, R2 and R3 have the meanings given in the specification and claims.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: July 9, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Matthias Hoffmann, Birgit Jung, Ulrike Kuefner-Muehl, Christopher John Montague Meade
  • Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
    Patent number: 6288277
    Abstract: The present invention relates to new phenylamine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: September 11, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6265612
    Abstract: The present invention relates to new benzamidine derivatives, processes for preparing them and their use in pharmaceutical compositions.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: July 24, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
    Patent number: 6197824
    Abstract: Novel benzamidines, having LTB4-antagonistic activity, of the formula methods for their preparation, their and their use as medicaments.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: March 6, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Kurt Schromm, Ralf Anderskewitz, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade
  • Phenylamidine derivatives, a process for preparing the same and their use as medicaments
    Patent number: 6127423
    Abstract: The invention relates to new phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 3, 2000
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Franz Birke, Hans Michael Jennewein, Christopher John Montague Meade, Andreas Ding
  • Use of Epinastine for the treatment of pain
    Patent number: 5942503
    Abstract: Disclosed herein is the use of epinastine for the treatment of pain, including migraine, Bing-Horton syndrome, tension headaches, muscle pain, inflammatory pain, and neuralgias. Epinastine may also be administered in combination with an additional analgesic for treating pain.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: August 24, 1999
    Assignee: Boehringer Indelheim KG
    Inventors: Birgit Jung, Christopher John Montague Meade, Michel Pairet